Virgil T. Gaddy, Ph.D. - Publications
Affiliations: | 2007 | Medical College of Georgia, Augusta, GA, United States |
Area:
Oncology, Cell Biology, Molecular BiologyYear | Citation | Score | |||
---|---|---|---|---|---|
2008 | Samaddar JS, Gaddy VT, Duplantier J, Thandavan SP, Shah M, Smith MJ, Browning D, Rawson J, Smith SB, Barrett JT, Schoenlein PV. A role for macroautophagy in protection against 4-hydroxytamoxifen-induced cell death and the development of antiestrogen resistance. Molecular Cancer Therapeutics. 7: 2977-87. PMID 18790778 DOI: 10.1158/1535-7163.Mct-08-0447 | 0.606 | |||
2007 | Schoenlein PV, Hou M, Samaddar JS, Gaddy VT, Thangaraju M, Lewis J, Johnson M, Ganapathy V, Kallab A, Barrett JT. Downregulation of retinoblastoma protein is involved in the enhanced cytotoxicity of 4-hydroxytamoxifen plus mifepristone combination therapy versus antiestrogen monotherapy of human breast cancer. International Journal of Oncology. 31: 643-55. PMID 17671693 DOI: 10.3892/Ijo.31.3.643 | 0.584 | |||
2004 | Gaddy VT, Barrett JT, Delk JN, Kallab AM, Porter AG, Schoenlein PV. Mifepristone induces growth arrest, caspase activation, and apoptosis of estrogen receptor-expressing, antiestrogen-resistant breast cancer cells. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 5215-25. PMID 15297425 DOI: 10.1158/1078-0432.Ccr-03-0637 | 0.608 | |||
Show low-probability matches. |